▼ -3.39% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for National Health Investors in the last 3 months. The average price target is $64.29, with a high forecast of $94.00 and a low forecast of $40.00. The average price target represents a -3.39% upside from the last price of $66.54.
The current consensus among 8 investment analysts is to hold stock in National Health Investors. This rating has held steady since February 2020, when it changed from a Sell consensus rating.
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.